{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:21:23Z","timestamp":1791390083944,"version":"4.3.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:00:00Z","timestamp":1731888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s11064-024-04258-x","type":"journal-article","created":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T00:02:06Z","timestamp":1731888126000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Atractylenolide-I Attenuates MPTP\/MPP+\u2011Mediated Oxidative Stress in Parkinson\u2019s Disease Through SIRT1\/PGC\u20111\u03b1\/Nrf2 Axis"],"prefix":"10.1007","volume":"50","author":[{"given":"Ya","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,18]]},"reference":[{"key":"4258_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397","journal-title":"Lancet Neurol"},{"key":"4258_CR2","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","volume":"91","author":"J Jankovic","year":"2020","unstructured":"Jankovic J, Tan EK (2020) Parkinson\u2019s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91:795\u2013808","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4258_CR3","doi-asserted-by":"publisher","first-page":"101263","DOI":"10.1016\/j.arr.2021.101263","volume":"67","author":"PA Dionisio","year":"2021","unstructured":"Dionisio PA, Amaral JD, Rodrigues CMP (2021) Oxidative stress and regulated cell death in Parkinson\u2019s disease. Ageing Res Rev 67:101263","journal-title":"Ageing Res Rev"},{"key":"4258_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","volume":"16","author":"J Dorszewska","year":"2021","unstructured":"Dorszewska J, Kowalska M, Prendecki M, Piekut T, Kozlowska J, Kozubski W (2021) Oxidative stress factors in Parkinson\u2019s disease. Neural Regen Res 16:1383\u20131391","journal-title":"Neural Regen Res"},{"key":"4258_CR5","first-page":"422","volume":"21","author":"M Mustapha","year":"2021","unstructured":"Mustapha M, Mat Taib CN (2021) MPTP-induced mouse model of Parkinson\u2019s disease: a promising direction of therapeutic strategies. Bosn J Basic Med Sci 21:422\u2013433","journal-title":"Bosn J Basic Med Sci"},{"key":"4258_CR6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neuro.2021.10.003","volume":"87","author":"Q Song","year":"2021","unstructured":"Song Q, Peng S, Zhu X (2021) Baicalein protects against MPP(+)\/MPTP-induced neurotoxicity by ameliorating oxidative stress in SH-SY5Y cells and mouse model of Parkinson\u2019s disease. Neurotoxicology 87:188\u2013194","journal-title":"Neurotoxicology"},{"key":"4258_CR7","doi-asserted-by":"crossref","unstructured":"More S, Choi DK (2017) Neuroprotective Role of Atractylenolide-I in an In Vitro and In Vivo Model of Parkinson\u2019s Disease. Nutrients 9","DOI":"10.3390\/nu9050451"},{"key":"4258_CR8","doi-asserted-by":"crossref","unstructured":"Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, Li Y, Wan C, So KM, Liu D, Frieden M, Fang Y, Mosley AL, He X, Zhang X, Sandusky GE, Liu Y, Meroueh SO, Zhang C, Wijeratne AB, Huang C, Ji G, Lu X (2021) Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation. J Clin Invest 131","DOI":"10.1172\/JCI146832"},{"key":"4258_CR9","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/jcsm.13079","volume":"13","author":"M Fan","year":"2022","unstructured":"Fan M, Gu X, Zhang W, Shen Q, Zhang R, Fang Q, Wang Y, Guo X, Zhang X, Liu X (2022) Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles. J Cachexia Sarcopenia Muscle 13:2724\u20132739","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4258_CR10","doi-asserted-by":"publisher","first-page":"797499","DOI":"10.3389\/fphar.2022.797499","volume":"13","author":"Z Du","year":"2022","unstructured":"Du Z, Ma Z, Lai S, Ding Q, Hu Z, Yang W, Qian Q, Zhu L, Dou X, Li S (2022) Atractylenolide I ameliorates Acetaminophen-Induced Acute Liver Injury via the TLR4\/MAPKs\/NF-kappaB signaling pathways. Front Pharmacol 13:797499","journal-title":"Front Pharmacol"},{"key":"4258_CR11","doi-asserted-by":"crossref","unstructured":"More SV, Choi DK (2017) Atractylenolide-I protects Human SH-SY5Y cells from 1-Methyl-4-phenylpyridinium-induced apoptotic cell death. Int J Mol Sci 18","DOI":"10.3390\/ijms18051012"},{"key":"4258_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yexcr.2017.02.040","volume":"353","author":"W Li","year":"2017","unstructured":"Li W, Zhi W, Liu F, He Z, Wang X, Niu X (2017) Atractylenolide I restores HO-1 expression and inhibits Ox-LDL-induced VSMCs proliferation, migration and inflammatory responses in vitro. Exp Cell Res 353:26\u201334","journal-title":"Exp Cell Res"},{"key":"4258_CR13","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2174\/1566524022666220811161111","volume":"23","author":"R Xu","year":"2023","unstructured":"Xu R, Liu X, Tian M, Chen D (2023) Atractylodes-I overcomes the oxidative stress-induced Colonic Mucosal epithelial cells dysfunction to prevent irritable Bowel Syndrome Via modulating the miR-34a-5p-LDHA signaling pathway. Curr Mol Med 23:825\u2013833","journal-title":"Curr Mol Med"},{"key":"4258_CR14","doi-asserted-by":"publisher","first-page":"300060521993315","DOI":"10.1177\/0300060521993315","volume":"49","author":"C Sun","year":"2021","unstructured":"Sun C, Zhang X, Yu F, Liu C, Hu F, Liu L, Chen J, Wang J (2021) Atractylenolide I alleviates ischemia\/reperfusion injury by preserving mitochondrial function and inhibiting caspase-3 activity. J Int Med Res 49:300060521993315","journal-title":"J Int Med Res"},{"key":"4258_CR15","doi-asserted-by":"crossref","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB (2023) PGC-1alpha is a Master Regulator of mitochondrial lifecycle and ROS stress response. Antioxidants (Basel) 12","DOI":"10.3390\/antiox12051075"},{"key":"4258_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biochi.2019.12.001","volume":"170","author":"D Liang","year":"2020","unstructured":"Liang D, Zhuo Y, Guo Z, He L, Wang X, He Y, Li L, Dai H (2020) SIRT1\/PGC-1 pathway activation triggers autophagy\/mitophagy and attenuates oxidative damage in intestinal epithelial cells. Biochimie 170:10\u201320","journal-title":"Biochimie"},{"key":"4258_CR17","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/tox.23885","volume":"38","author":"PL Hsieh","year":"2023","unstructured":"Hsieh PL, Tsai KL, Chou WC, Wu CH, Jou IM, Tu YK, Ma CH (2023) Cisplatin triggers oxidative stress, apoptosis and pro-inflammatory responses by inhibiting the SIRT1-mediated Nrf2 pathway in chondrocytes. Environ Toxicol 38:2476\u20132486","journal-title":"Environ Toxicol"},{"key":"4258_CR18","doi-asserted-by":"crossref","unstructured":"Ngo V, Duennwald ML (2022) Nrf2 and oxidative stress: a General Overview of mechanisms and implications in Human Disease. Antioxid (Basel) 11","DOI":"10.3390\/antiox11122345"},{"key":"4258_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainresbull.2021.11.001","volume":"178","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Peng L, Li Y, Zhao Y (2022) Silent information regulator 1 ameliorates oxidative stress injury via PGC-1alpha\/PPARgamma-Nrf2 pathway after ischemic stroke in rat. Brain Res Bull 178:37\u201348","journal-title":"Brain Res Bull"},{"key":"4258_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2022.12.081","volume":"195","author":"Y Yao","year":"2023","unstructured":"Yao Y, Chen T, Wu H, Yang N, Xu S (2023) Melatonin attenuates bisphenol A-induced colon injury by dual targeting mitochondrial dynamics and Nrf2 antioxidant system via activation of SIRT1\/PGC-1alpha signaling pathway. Free Radic Biol Med 195:13\u201322","journal-title":"Free Radic Biol Med"},{"key":"4258_CR21","doi-asserted-by":"publisher","first-page":"770744","DOI":"10.3389\/fimmu.2021.770744","volume":"12","author":"DY Xia","year":"2021","unstructured":"Xia DY, Yuan JL, Jiang XC, Qi M, Lai NS, Wu LY, Zhang XS (2021) SIRT1 promotes M2 Microglia polarization via reducing ROS-Mediated NLRP3 Inflammasome Signaling after Subarachnoid Hemorrhage. Front Immunol 12:770744","journal-title":"Front Immunol"},{"key":"4258_CR22","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.1038\/s41418-021-00767-2","volume":"28","author":"M Zhao","year":"2021","unstructured":"Zhao M, Wang B, Zhang C, Su Z, Guo B, Zhao Y, Zheng R (2021) The DJ1-Nrf2-STING axis mediates the neuroprotective effects of withaferin A in Parkinson\u2019s disease. Cell Death Differ 28:2517\u20132535","journal-title":"Cell Death Differ"},{"key":"4258_CR23","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1093\/brain\/awad064","volume":"146","author":"KML Cramb","year":"2023","unstructured":"Cramb KML, Beccano-Kelly D, Cragg SJ, Wade-Martins R (2023) Impaired dopamine release in Parkinson\u2019s disease. Brain 146:3117\u20133132","journal-title":"Brain"},{"key":"4258_CR24","doi-asserted-by":"publisher","first-page":"e13031","DOI":"10.1111\/acel.13031","volume":"18","author":"BG Trist","year":"2019","unstructured":"Trist BG, Hare DJ, Double KL (2019) Oxidative stress in the aging substantia nigra and the etiology of Parkinson\u2019s disease. Aging Cell 18:e13031","journal-title":"Aging Cell"},{"key":"4258_CR25","doi-asserted-by":"crossref","unstructured":"Percario S, da Silva Barbosa A, Varela ELP, Gomes ARQ, Ferreira MES, de Nazare Araujo Moreira T, Dolabela MF (2020) Oxidative Stress in Parkinson\u2019s Disease: Potential Benefits of Antioxidant Supplementation. Oxid Med Cell Longev 2020:2360872","DOI":"10.1155\/2020\/2360872"},{"key":"4258_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13041-017-0340-9","volume":"10","author":"L Puspita","year":"2017","unstructured":"Puspita L, Chung SY, Shim JW (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10:53","journal-title":"Mol Brain"},{"key":"4258_CR27","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s12035-015-9103-8","volume":"53","author":"C Klemann","year":"2016","unstructured":"Klemann C, Martens GJM, Poelmans G, Visser JE (2016) Validity of the MPTP-Treated mouse as a model for Parkinson\u2019s Disease. Mol Neurobiol 53:1625\u20131636","journal-title":"Mol Neurobiol"},{"key":"4258_CR28","doi-asserted-by":"publisher","first-page":"104792","DOI":"10.1016\/j.neubiorev.2022.104792","volume":"140","author":"A Narmashiri","year":"2022","unstructured":"Narmashiri A, Abbaszadeh M, Ghazizadeh A (2022) The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on the cognitive and motor functions in rodents: a systematic review and meta-analysis. Neurosci Biobehav Rev 140:104792","journal-title":"Neurosci Biobehav Rev"},{"key":"4258_CR29","doi-asserted-by":"publisher","first-page":"111644","DOI":"10.1016\/j.fct.2020.111644","volume":"144","author":"X Li","year":"2020","unstructured":"Li X, Zhang J, Zhang X, Dong M (2020) Puerarin suppresses MPP(+)\/MPTP-induced oxidative stress through an Nrf2-dependent mechanism. Food Chem Toxicol 144:111644","journal-title":"Food Chem Toxicol"},{"key":"4258_CR30","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.1007\/s12035-016-0147-1","volume":"54","author":"MP Cunha","year":"2017","unstructured":"Cunha MP, Pazini FL, Lieberknecht V, Budni J, Oliveira A, Rosa JM, Mancini G, Mazzardo L, Colla AR, Leite MC, Santos ARS, Martins DF, de Bem AF, Goncalves CAS, Farina M, Rodrigues ALS (2017) MPP(+)-Lesioned mice: an experimental model of motor, emotional, Memory\/Learning, and Striatal Neurochemical dysfunctions. Mol Neurobiol 54:6356\u20136377","journal-title":"Mol Neurobiol"},{"key":"4258_CR31","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li X, Feng Y, Wang XX, Truong D, Wu YC (2020) The critical role of SIRT1 in Parkinson\u2019s Disease: mechanism and therapeutic considerations. Aging Dis 11:1608\u20131622","journal-title":"Aging Dis"},{"key":"4258_CR32","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12868-017-0364-1","volume":"18","author":"P Singh","year":"2017","unstructured":"Singh P, Hanson PS, Morris CM (2017) SIRT1 ameliorates oxidative stress induced neural cell death and is down-regulated in Parkinson\u2019s disease. BMC Neurosci 18:46","journal-title":"BMC Neurosci"},{"key":"4258_CR33","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12640-017-9770-5","volume":"32","author":"JH Koo","year":"2017","unstructured":"Koo JH, Cho JY (2017) Treadmill Exercise attenuates alpha-synuclein levels by promoting mitochondrial function and autophagy possibly via SIRT1 in the chronic MPTP\/P-Induced Mouse Model of Parkinson\u2019s Disease. Neurotox Res 32:473\u2013486","journal-title":"Neurotox Res"},{"key":"4258_CR34","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s10072-020-04711-z","volume":"42","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Zhu X, Zhou Y, Zhang D (2021) Reduced serum SIRT1 levels in patients with Parkinson\u2019s disease: a cross-sectional study in China. Neurol Sci 42:1835\u20131841","journal-title":"Neurol Sci"},{"key":"4258_CR35","doi-asserted-by":"publisher","first-page":"107595","DOI":"10.1016\/j.clineuro.2023.107595","volume":"225","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang C, Xu W, Chen J, Tuo J, Wen Y, Huang Z, Zeng R (2023) Serum Sirtuin1 level decreases in Parkinson\u2019s disease and vascular parkinsonism: a prospective observational study. Clin Neurol Neurosurg 225:107595","journal-title":"Clin Neurol Neurosurg"},{"key":"4258_CR36","doi-asserted-by":"publisher","first-page":"102134","DOI":"10.1016\/j.redox.2021.102134","volume":"47","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao M, Wang B, Su Z, Guo B, Qin L, Zhang W, Zheng R (2021) The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of Celastrol in Parkinson\u2019s disease. Redox Biol 47:102134","journal-title":"Redox Biol"},{"key":"4258_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-021-02289-7","volume":"18","author":"S Xie","year":"2021","unstructured":"Xie S, Jiang X, Doycheva DM, Shi H, Jin P, Gao L, Liu R, Xiao J, Hu X, Tang J, Zhang L, Zhang JH (2021) Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1\/PGC-1alpha\/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats. J Neuroinflammation 18:226","journal-title":"J Neuroinflammation"},{"key":"4258_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.brainresbull.2022.04.012","volume":"185","author":"X Chen","year":"2022","unstructured":"Chen X, Wei G, Li D, Fan Y, Zeng Y, Qian Z, Jia Z, Tang Y, Shi Y, Wu H, Li X (2022) Sirtuin 1 alleviates microglia-induced inflammation by modulating the PGC-1alpha\/Nrf2 pathway after traumatic brain injury in male rats. Brain Res Bull 185:28\u201338","journal-title":"Brain Res Bull"},{"key":"4258_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/tox.22736","volume":"34","author":"MW Zhao","year":"2019","unstructured":"Zhao MW, Yang P, Zhao LL (2019) Chlorpyrifos activates cell pyroptosis and increases susceptibility on oxidative stress-induced toxicity by miR-181\/SIRT1\/PGC-1alpha\/Nrf2 signaling pathway in human neuroblastoma SH-SY5Y cells: implication for association between chlorpyrifos and Parkinson\u2019s disease. Environ Toxicol 34:699\u2013707","journal-title":"Environ Toxicol"},{"key":"4258_CR40","doi-asserted-by":"publisher","first-page":"174236","DOI":"10.1016\/j.ejphar.2021.174236","volume":"907","author":"M Chen","year":"2021","unstructured":"Chen M, Wang Z, Zhou W, Lu C, Ji T, Yang W, Jin Z, Tian Y, Lei W, Wu S, Fu Q, Wu Z, Wu X, Han M, Fang M, Yang Y (2021) SIRT1\/PGC-1alpha signaling activation by mangiferin attenuates cerebral hypoxia\/reoxygenation injury in neuroblastoma cells. Eur J Pharmacol 907:174236","journal-title":"Eur J Pharmacol"},{"key":"4258_CR41","doi-asserted-by":"publisher","first-page":"109793","DOI":"10.1016\/j.intimp.2023.109793","volume":"116","author":"I Khan","year":"2023","unstructured":"Khan I, Preeti K, Kumar R, Kumar Khatri D, Bala Singh S (2023) Piceatannol promotes neuroprotection by inducing mitophagy and mitobiogenesis in the experimental diabetic peripheral neuropathy and hyperglycemia-induced neurotoxicity. Int Immunopharmacol 116:109793","journal-title":"Int Immunopharmacol"},{"key":"4258_CR42","doi-asserted-by":"publisher","first-page":"102534","DOI":"10.1016\/j.redox.2022.102534","volume":"58","author":"CC Chao","year":"2022","unstructured":"Chao CC, Huang CL, Cheng JJ, Chiou CT, Lee IJ, Yang YC, Hsu TH, Yei CE, Lin PY, Chen JJ, Huang NK (2022) SRT1720 as an SIRT1 activator for alleviating paraquat-induced models of Parkinson\u2019s disease. Redox Biol 58:102534","journal-title":"Redox Biol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04258-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-024-04258-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-024-04258-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T07:08:55Z","timestamp":1738393735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-024-04258-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["4258"],"URL":"https:\/\/doi.org\/10.1007\/s11064-024-04258-x","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,18]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"18"}}